# CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris

> **NCT07681388** · NA · RECRUITING · sponsor: **Jinbo Chen** · enrollment: 3 (estimated)

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **BIOLOGICAL:** Autologous CD19 CAR-T cells

## Key facts

- **NCT ID:** NCT07681388
- **Lead sponsor:** Jinbo Chen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2026-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681388, "CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*